RevMAb is a South San Francisco based Biotech company focused on the development and production of Rabbit and Goat monoclonal antibodies using revolutionary b cell cloning technology. RevMAb technology allows for the development of monoclonal antibodies without the use of traditional cell fusion and hybridoma methods. Instead we directly screen antibodies from immunized Rabbit or Goat B cells using various assays. After identifying the desired B cells, we then clone cDNA and perform recombinant antibody production using transient and stable mammalian cell expression. Our technology has so far been applied to develop quality rabbit and goat monoclonal antibodies for research, diagnostic, and therapeutic use.